Overview
Role of Topical Putrescine (Fibrostat) for Prevention of Hypertrophic Scars in Mammoplasty Patients
Status:
Completed
Completed
Trial end date:
2016-07-15
2016-07-15
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
Linked to previous Clinical Trial E92:069 in which biochemical effect of 1,4 diaminobutane was studied in human scar harvested at revision surgery after a 12 week application. Analytical data was collected in this phase of the work completed in 1999. This was then followed by clinical correlation in a scar prevention model with topical application of 1,4 diaminobutane for 12 weeks and measuring duredness , as well photographic and POSAS score data for quality of scar formation.Phase:
Phase 3Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
University of Manitoba
Criteria
Inclusion Criteria: Undergoing breast reduction surgery -Exclusion Criteria: Not pregnant or lactating
-